awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45066717-2A7F6A47-9975-44F4-962B-C9D6951FA40C
Q45066717-2A7F6A47-9975-44F4-962B-C9D6951FA40C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45066717-2A7F6A47-9975-44F4-962B-C9D6951FA40C
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
P2860
Q45066717-2A7F6A47-9975-44F4-962B-C9D6951FA40C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45066717-2A7F6A47-9975-44F4-962B-C9D6951FA40C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ba67953186f83db5fc64d00b28f3f20112c43ad
P2860
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.